4.5 Article

Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Optimum Timing of Blood Tests for Monitoring Patients With Clostridium difficile-Associated Diarrhea

Aneel Bhangu et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2016)

Article Immunology

Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain

Sarah A. Kuehne et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

Review Gastroenterology & Hepatology

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Christina M. Surawicz et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Editorial Material Immunology

The Role of Gut Inflammation in Recurrent Clostridium difficile-Associated Disease

Mary Beth Yacyshyn et al.

CLINICAL INFECTIOUS DISEASES (2013)

Editorial Material Immunology

Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?

Dale N. Gerding et al.

CLINICAL INFECTIOUS DISEASES (2013)

Article Microbiology

Quantitative Fecal Lactoferrin in Toxin-Positive and Toxin-Negative Clostridium difficile Specimens

P. Rocco LaSala et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2013)

Article Public, Environmental & Occupational Health

Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection

I. Baker et al.

JOURNAL OF HOSPITAL INFECTION (2013)

Article Medicine, General & Internal

Urinary Tract Infection in Male Veterans Treatment Patterns and Outcomes

Dimitri M. Drekonja et al.

JAMA INTERNAL MEDICINE (2013)

Article Immunology

Clostridium difficile Ribotype Does Not Predict Severe Infection

Seth T. Walk et al.

CLINICAL INFECTIOUS DISEASES (2012)

Editorial Material Immunology

027, 078, and Others: Going Beyond the Numbers (and Away From the Hypervirulence)

Frederic Barbut et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Infectious Diseases

Outcomes in patients tested for Clostridium difficile toxins

Christopher R. Polage et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)

Article Infectious Diseases

Clostridium difficile prevalence rates in a large healthcare system stratified according to patient population, age, gender, and specimen consistency

J. H. Boone et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)

Review Public, Environmental & Occupational Health

Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review

M. G. Bloomfield et al.

JOURNAL OF HOSPITAL INFECTION (2012)

Article Public, Environmental & Occupational Health

Comparison of Clinical Severity Score Indices for Clostridium difficile Infection

Shigeki Fujitani et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)

Article Gastroenterology & Hepatology

Clostridium difficile Strain NAP-1 Is Not Associated With Severe Disease in a Nonepidemic Setting

Jeffrey Cloud et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

Jennifer R. O'Connor et al.

GASTROENTEROLOGY (2009)

Letter Public, Environmental & Occupational Health

Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile

S. W. Pawlowski et al.

JOURNAL OF HOSPITAL INFECTION (2009)

Article Immunology

Clinical Risk Factors for Severe Clostridium difficile-associated Disease

Timothy J. Henrich et al.

EMERGING INFECTIOUS DISEASES (2009)

Article Multidisciplinary Sciences

Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study

Oliver W. Morgan et al.

PLOS ONE (2008)